中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
GXYLT2 serves as a prognostic biomarker and is associated with b-catenin activation and gastric cancer aggressiveness

文献类型:期刊论文

作者Yang, Jiale2,3; Wu, Jiajun4; Chen, Ziqiang2,3; Hou, Xiangyun2,3; Li, Xiaojing2,3; Liu, Zhaorui5; Yin, Kai5; Pang, Tao5; Huang, Ruimin2,3; Yan, Jun1
刊名GENES & DISEASES
出版日期2026-03-01
卷号13期号:2页码:16
关键词Gastric cancer GXYLT2 Prognostic biomarker Tumor aggressiveness Wnt/beta-catenin signaling
ISSN号2352-4820
DOI10.1016/j.gendis.2025.101673
通讯作者Pang, Tao(pangtao7667@163.com) ; Huang, Ruimin(rmhuang@simm.ac.cn) ; Yan, Jun(yan_jun@fudan.edu.cn)
英文摘要Gastric cancer (GC) is a significant global health challenge due to its high incidence and mortality rate. However, the existing classification methods for GC still have limitations. Given the pivotal role of aberrant glycosylation in GC progression, there is a compelling need to develop a novel molecular classification for this disease. Using a comprehensive analysis of 186 glycogenes across seven public datasets encompassing 1547 GC patients, a 12-glycogene signature-based molecular classification was established, which was linked to tumor stage and prognosis. Among them, the overexpression of glucoside xylosyltransferase 2 (GXYLT2) was positively associated with tumor stage, diffuse subtype, and unfavorable survival outcomes in GC patients. Furthermore, GXYLT2 depletion significantly inhibited the proliferation, invasion, and sphere formation capacities in HGC-27, MKN1, and MKN45 GC cells with diffuse-subtype features, whereas its ectopic expression in AGS and MKN74 GC cells with intestinal subtype did not enhance their aggressive properties. Moreover, RNA sequencing analysis revealed that GXYLT2 knockdown resulted in the decrease of Wnt/b-catenin signaling, which was corroborated by TOPFlash reporter activity, b-catenin phosphorylation, immunofluorescence staining, and nuclear-cytoplasmic separation assays for its nuclear location, via the activation of PP2A complex dependent on GXYLT2-PP2A Aa interaction. Notably, GXYLT2 knockdown significantly suppressed tumorigenicity in vivo. Taken together, we identified GXYLT2 as a potential prognostic biomarker for GC patients, and targeting GXYLT2 suppressed the tumor aggressiveness and inhibited the Wnt/b-catenin pathway, which may provide a potential therapeutic target for GC patients. 2025 The Authors. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co., Ltd. This is an open access article under the CC BY license (http://creativecommons.org/ licenses/by/4.0/).
WOS关键词IDENTIFICATION ; SUBTYPES ; DIFFUSE ; CLASSIFICATION ; EXPRESSION ; CARCINOMA ; STOMACH
资助项目National Natural Science Foundation of China[82172001] ; Shanghai Municipal Science and Technology Major Project (China) ; Navy Medical University Foundation (China)[2021MS07]
WOS研究方向Biochemistry & Molecular Biology ; Genetics & Heredity
语种英语
WOS记录号WOS:001643867400001
出版者KEAI PUBLISHING LTD
源URL[http://119.78.100.183/handle/2S10ELR8/322423]  
专题中国科学院上海药物研究所
通讯作者Pang, Tao; Huang, Ruimin; Yan, Jun
作者单位1.Fudan Univ, Lab Anim Ctr, 130 Dongan Rd, Shanghai 200032, Peoples R China
2.Chinese Acad Sci, Shanghai Inst Mat Med, Ctr Drug Safety Evaluat & Res, 555 Zuchongzhi Rd, Shanghai 201203, Peoples R China
3.Univ Chinese Acad Sci, Beijing 100049, Peoples R China
4.Fudan Univ, Sch Life Sci, State Key Lab Genet Engn, Shanghai 200438, Peoples R China
5.Naval Med Univ, Dept Gastrointestinal Surg, Affiliated Hosp 1, 168 Changhai Rd, Shanghai 200433, Peoples R China
推荐引用方式
GB/T 7714
Yang, Jiale,Wu, Jiajun,Chen, Ziqiang,et al. GXYLT2 serves as a prognostic biomarker and is associated with b-catenin activation and gastric cancer aggressiveness[J]. GENES & DISEASES,2026,13(2):16.
APA Yang, Jiale.,Wu, Jiajun.,Chen, Ziqiang.,Hou, Xiangyun.,Li, Xiaojing.,...&Yan, Jun.(2026).GXYLT2 serves as a prognostic biomarker and is associated with b-catenin activation and gastric cancer aggressiveness.GENES & DISEASES,13(2),16.
MLA Yang, Jiale,et al."GXYLT2 serves as a prognostic biomarker and is associated with b-catenin activation and gastric cancer aggressiveness".GENES & DISEASES 13.2(2026):16.

入库方式: OAI收割

来源:上海药物研究所

浏览0
下载0
收藏0
其他版本

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。